Details of the Drug

General Information of Drug (ID: DMSNCPD)

• Drug Name: AL 001
• Synonyms: Latozinemab

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 1/2	[1]

• Cross-matching ID: TTD ID: D2A6QI

References

• [1] ClinicalTrials.gov (NCT05363293) A Multiple-dose, Steady-state, Double-blind, Ascending Dose, Safety, Tolerability, Pharmacokinetic Study of AL001 in Patients With Mild to Moderate Alzheimer\'s Disease and Healthy Adult Subjects ("MAD Study"). U.S.National Institutes of Health.